search
Back to results

Evaluation of the MANOS Carpal Tunnel Release System in Patients With Carpal Tunnel Syndrome

Primary Purpose

Carpal Tunnel Syndrome

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
MANOS CTR™
Sponsored by
Thayer Intellectual Property, Inc.
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Carpal Tunnel Syndrome

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient is scheduled to undergo carpal tunnel release surgery.
  • Patient has chronic Carpal Tunnel Syndrome with persistent symptoms despite non-operative treatment, or refusal of non-operative treatment, with one or more of the following: splinting, NSAIDs or corticosteroid injections.
  • Carpal Tunnel Syndrome must be confirmed by positive results of Electromyography (EMG) and Nerve Conduction Velocity (NCV) tests.
  • Patient is a male or non-pregnant, non-lactating female.
  • Patient is 18-75 years of age, inclusive.
  • Female patients of child-bearing potential, including those who have had a tubal ligation, but excluding those who have not experienced a menstrual period for at least two years, must have a negative urine pregnancy test at Screening.
  • Patient must voluntarily provide written, informed consent.

Exclusion Criteria:

  • Patient has a prior or current musculoskeletal or neurologic condition that limits strength, motion, or sensation in the affected hand.
  • Patient has a medical condition that precludes the use of anesthetic required for surgery.
  • Patient has an ipsilateral injury or other conditions affecting hand function.
  • Patient has acute CTS resulting from an injury (e.g., fracture).
  • Patient has had previous CTR surgery on the affected hand.
  • Patient has psychiatric history, head injury or any other condition which, in the Investigator's opinion, would prevent patient from complying with post-operative hand therapy or follow-up visits.

Sites / Locations

  • The Hand Treatment Center
  • Neurospine Institute Medical Group
  • William Bowen, MD Orthopedic Surgery

Outcomes

Primary Outcome Measures

Gather clinical outcome data on the safety and efficacy of the MANOS Carpal Tunnel Release System.
Clinical outcome data that will be evaluated: Carpal Tunnel Syndrome Questionnaire (CTSQ) Scar sensitivity Hand sensation Grip and pinch strength Hand dexterity

Secondary Outcome Measures

Safety information will be evaluated by collecting the type, frequency, severity, device, and procedure-relatedness of adverse events.

Full Information

First Posted
October 6, 2011
Last Updated
January 13, 2013
Sponsor
Thayer Intellectual Property, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01450735
Brief Title
Evaluation of the MANOS Carpal Tunnel Release System in Patients With Carpal Tunnel Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
January 2013
Overall Recruitment Status
Terminated
Why Stopped
Enrollment did not reach our intended sample size due to availability of CTR with MANOS outside of the study.
Study Start Date
October 2011 (undefined)
Primary Completion Date
November 2012 (Actual)
Study Completion Date
November 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Thayer Intellectual Property, Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The MANOS device is a carpal tunnel blade used to perform carpal tunnel release (CTR). CTR is indicated for the treatment of Carpal Tunnel Syndrome when conservative therapy fails. This study is being conducted to evaluate the safety and effectiveness of CTR with the MANOS device.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
MANOS CTR™
Intervention Description
The MANOS device is a carpal tunnel blade used to release the transverse carpal ligament in order to provide relief for Carpal Tunnel Syndrome.
Primary Outcome Measure Information:
Title
Gather clinical outcome data on the safety and efficacy of the MANOS Carpal Tunnel Release System.
Description
Clinical outcome data that will be evaluated: Carpal Tunnel Syndrome Questionnaire (CTSQ) Scar sensitivity Hand sensation Grip and pinch strength Hand dexterity
Time Frame
Baseline throughout 12 weeks post-operatively
Secondary Outcome Measure Information:
Title
Safety information will be evaluated by collecting the type, frequency, severity, device, and procedure-relatedness of adverse events.
Time Frame
Baseline throughout 12 weeks post-operatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is scheduled to undergo carpal tunnel release surgery. Patient has chronic Carpal Tunnel Syndrome with persistent symptoms despite non-operative treatment, or refusal of non-operative treatment, with one or more of the following: splinting, NSAIDs or corticosteroid injections. Carpal Tunnel Syndrome must be confirmed by positive results of Electromyography (EMG) and Nerve Conduction Velocity (NCV) tests. Patient is a male or non-pregnant, non-lactating female. Patient is 18-75 years of age, inclusive. Female patients of child-bearing potential, including those who have had a tubal ligation, but excluding those who have not experienced a menstrual period for at least two years, must have a negative urine pregnancy test at Screening. Patient must voluntarily provide written, informed consent. Exclusion Criteria: Patient has a prior or current musculoskeletal or neurologic condition that limits strength, motion, or sensation in the affected hand. Patient has a medical condition that precludes the use of anesthetic required for surgery. Patient has an ipsilateral injury or other conditions affecting hand function. Patient has acute CTS resulting from an injury (e.g., fracture). Patient has had previous CTR surgery on the affected hand. Patient has psychiatric history, head injury or any other condition which, in the Investigator's opinion, would prevent patient from complying with post-operative hand therapy or follow-up visits.
Facility Information:
Facility Name
The Hand Treatment Center
City
Hayward
State/Province
California
ZIP/Postal Code
94545
Country
United States
Facility Name
Neurospine Institute Medical Group
City
San Francisco
State/Province
California
ZIP/Postal Code
94115
Country
United States
Facility Name
William Bowen, MD Orthopedic Surgery
City
Willits
State/Province
California
ZIP/Postal Code
95490
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the MANOS Carpal Tunnel Release System in Patients With Carpal Tunnel Syndrome

We'll reach out to this number within 24 hrs